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Abstract This study aimed to establish the interplay
between body mass, adiposity, ageing and determinants
of skeletal muscle strength. One hundred and two un-
trained healthy women categorised by age into young
(Y) (mean±SD, 26.7±9.4 years) vs. old (O) (65.1±
7.2 years) were assessed for body fat, lean mass, plantar
flexion and dorsiflexion maximum voluntary isometric
contraction (MVC) torque, muscle activation capacity
and antagonist muscle co-contraction. MVC torque nor-
malised to body mass in the obese group was 35 and
29 % lower (p<0.05) in Y and 34 and 31 % lower
(p<0.05) in O, compared with underweight and normal
weight individuals, respectively. Y with ≥40 % body fat
had significantly lower activation than Y with <40 %
body fat (88.3 vs. 94.4%, p<0.05), but O did not exhibit
this effect. Co-contraction was affected by ageing
(16.1 % in O vs. 13.8 % in Y, p<0.05) but not body
composition. There were significant associations be-
tween markers of body composition, age, strength and
activation capacity, with the strongest correlation be-
tween muscle strength and total body mass (r2=0.508
in Y, p<0.001, vs. r2=0.204 in O, p<0.01). Further-
more, the age-related loss in plantar flexion (PF) MVC
torque was exacerbated in obese compared to under-
weight, normal weight and overweight individuals
(−0.96 vs. −0.54, −0.57 and −0.57 % per year,
p<0.05). The negative impact of adiposity on muscle
performance is associated with not only muscular but
also neural factors. Overall, the effects of ageing and
obesity on this system are somewhat cumulative.
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Introduction
Obesity is associated with high body fat and several co-
morbidities including lowered functional mobility, par-
ticularly in the elderly (Zoico et al. 2004). The latter
effect is likely linked to decreased strength to bodymass
ratio in obese compared with normal weight individuals
in both young (Maffiuletti et al. 2007) and aged popu-
lations (Rolland et al. 2004). Contributors to strength,
over and above muscle tissue content (Erskine et al.
2010a), are agonist muscle activation (Morse et al.
2004), antagonist co-contraction (Klein et al. 2001)
and tendon moment arm (Erskine et al. 2010a). Yet,
the link between obesity and the principal factors con-
tributing to decreased strength to body mass ratio in
both young and ageing populations has yet to be ex-
plored. The combined impact of ageing and obesity is of
particular interest, as strength is known to decline with
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ageing (Morse et al. 2005), yet it remains to be seen
what effect, if any, increased adiposity has on the
ageing-related sarcopenia and in particular on the neu-
romuscular components of muscle strength.
It could be hypothesised that obesity in both young
and old persons would load the antigravity muscles
causing hypertrophy, in amanner similar to being placed
in a hypergravity environment (Maffiuletti et al. 2007,
2013; Blimkie et al. 1990). Indeed, 3 weeks of simulated
hypergravity in young athletes wearing a weighted vest
ranging from 7 to 13 % of body weight from morning
until night increased participants’ muscle power (Bosco
et al. 1984, 1986; Bosco 1985). Interestingly, similar
increases in muscle power were demonstrated in post-
menopausal women who utilised weighted vests
(Klentrou et al. 2007). When relating this to an obese
individual who has carried excess weight continuously
for years, not weeks, strength gains may follow those
seen with resistance training, thus having both neural
and muscular underpinnings (Erskine et al. 2010b).
Although the loading intensity of increased adiposity
is not as high in the conventional resistance training
regimes, the volume of loading is likely to be higher
with lower loads being lifted during ‘repetitions’ of
daily tasks and over longer periods of time. In support
of this hypothesis, low-load, high-volume resistance
exercise has been shown to stimulate muscle protein
synthesis more than traditional high-load, low-volume
exercise (Burd et al. 2010).
In terms of the muscular factors of decreased
strength, muscle strength is 24.2 and 22.2 % higher
(absolute torque or torque normalised to thigh muscle
mass, respectively) in obese compared to non-obese
adolescent boys (Abdelmoula et al. 2012). In contrast,
lower limb maximum voluntary contraction (MVC)
torque and power (both absolute and normalised to
muscle volume) is lower in obese compared to non-
obese persons (Hilton et al. 2008). In terms of the neural
factors of decreased strength, one limiting factor could
be the central drive. However, studies report that in-
creased adiposity is in fact associated with increased
neural sympathetic drive (Alvarez et al. 2002). This
would therefore suggest that the deleterious effects of
weakness associated with high fat mass are muscular but
not neural in origin. However, a study reported a de-
crease in the muscle activation capacity (85.1 vs.
95.3 %) in obese compared to non-obese adolescent
males (Blimkie et al. 1990). Unfortunately, exercise
training status was not monitored in this study, and this
could account for differences in muscle activation
(Hakkinen et al. 1998). In another study, it was found
that obese individuals had greater fat-free mass yet
similar strength values compared to their normal weight
counterparts (Rolland et al. 2004), hence further
supporting the suggestion of obesity-related weakness
having a neural basis (e.g. decreased agonist activation
capacity). Moreover, whilst the expectation is that with
increased age, there will be a decrease in agonist acti-
vation capacity even in the absence of obesity (Morse
et al. 2004), it is unclear whether the above-described
decreased activation capacity seen in the adolescents
would be mirrored in adults and/or exacerbated in the
elderly.
Indeed, skeletal muscle ageing has been well docu-
mented and is characterised by lower muscle strength
(Morse et al. 2005; Onambele et al. 2006a, b), decreased
muscle volume (Thom et al. 2005), decreased agonist
activation (Morse et al. 2004) and increased antagonist
co-contraction (Klein et al. 2001). The consensus is that
many of these ageing effects are caused through de-
creased habitual physical activity levels and sarcopenia
(Rosenberg 1997). Hence, since there is a recognised
age-related prevalence in increased body fat percentage
termed sarcopenic obesity (Zamboni et al. 2008),
characterised by a combination of reduced skeletal mus-
cle mass and increased intramuscular fat (Hilton et al.
2008), obesity would further compound the ageing ef-
fects. In support of this hypothesis, sarcopenic obesity
would be expected to aggravate the impact of ageing on
physical functions including stair climbing, rising from
a chair and lifting objects (Rolland et al. 2009). How-
ever, Rolland and colleagues did not quantify either
agonist muscle activation capacity or antagonist co-
contraction (Rolland et al. 2004), thus potentially
masking the true impact of sarcopenic obesity.
The present study therefore aimed to contrast how
different levels of BMI vs. lean muscle mass vs. adipos-
ity impact on both muscular (absolute and normalised
MVC ankle joint torque) and neural factors (agonist
muscle activation, antagonist co-contraction) underly-
ing skeletal muscle function. The study also aimed to
determine whether the effects of ageing and adiposity
were additive. It was hypothesised that: (1) absolute
torque in both young and old obese individuals would
be higher, but torque relative to body mass lower, com-
pared to underweight, normal weight and overweight
individuals; (2) muscle activation would be significantly
lower in obese young and old individuals; and (3) the
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slope of the relationship between adiposity and joint
torque, or activation capacity, would be steeper in
the older individuals relative to their younger
counterparts.
Method
Participants
Untrained females (n=102) categorised by age into
young (Y) 18–49 years old or old (O) 50–80 years
old volunteered to take part in this study. Participants
were sub-categorised into four body mass index classi-
fications (BMI—body mass (kg)/stature2 (m)) into un-
derweight (BMI <20), normal (BMI 20–24.9), over-
weight (BMI 25–29.9) and obese (BMI >30). Group
information on age, stature and body mass is presented
in Table 1. Participants were excluded if there was any
issue with lower limb muscles/joints affecting their
mobility or ability to exert maximum force. Fasted
blood glucose levels were used as an indication of
undisclosed peripheral neuropathy, a condition which
has a detrimental effect on force production (Hilton
et al. 2008).
Ethical approval was obtained from the local ethics
committee, and all participants gave their written in-
formed consent prior to undertaking any assessment.
Body composition measure
Body composition analysis (body content of fat, lean
muscle and bone) was performed using a dual-energy
X-ray absorptiometry (DEXA) scanner (Hologic Dis-
covery: Vertec Scientific Ltd, UK) with participants
fasted for 12 h prior to scanning. Participants were laid
in a supine position throughout the 7-min scanning
procedure. Segmental analysis of the whole body scan
provided quantification for lean leg mass, later used in
the normalisation of the joint torque data. The android to
gynoid ratio (A/G) of each participant was calculated
using the Hologic APEX software (version 3.3). The
android region was classified as the area between the
mid-point of the lumbar spine to the top of the pelvis,
whilst the gynoid region was classified as the area
between the head of the femur and mid-thigh.
Table 1 Descriptive variables for BMI classifications in both young and old age classifications. TheA/G ratio (i.e. android/gynoid dimensional
comparison or waist-hip ratio), where it is >1.00, is utilised as an indicator of increased risk of cardiovascular disease (Folsom et al. 2000)
Young (18–49) Underweight (n=13) Normal (n=13) Overweight (n=10) Obese (n=18) BMI effect Ageing effect
Age (years) 23.0 (6.7) 23.2 (7.9) 23.6 (8.0) 30.9 (10.7) p=0.002 p=0.001
Height (cm) 167.5 (4.7) 164.1 (8.6) 162.8 (7.4) 166.5 (7.6) p=0.422 p=0.002
Body mass (kg) 52.7 (3.9) 58.3 (6.5) 74.6 (8.3) 97.5 (13.1) p<0.001 p=0.683
BMI (kg/m2) 18.8 (0.9) 21.6 (1.1) 28.1 (2.4) 35.2 (4.4) p<0.001 p=0.625
Body fat (%) 26.5 (3.9) 30.4 (3.5) 38.7 (5.9) 45.3 (3.9) p<0.001 p=0.001
Total body fat (kg) 13.7 (2.2) 17.2 (2.7) 28.5 (6.8) 43.2 (7.3) p<0.001 p=0.376
Total lean mass (kg) 35.7 (3.4) 37.2 (4.7) 42.0 (4.3) 49.4 (7.0) p<0.001 p=0.002
Fat mass leg (kg) 3.2 (0.5) 3.8 (0.6) 5.8 (1.8) 7.7 (1.5) p<0.001 p=0.859
A/G ratio 0.70 (0.09) 0.77 (0.12) 0.95 (0.14) 1.06 (0.08) p<0.001 p=0.062
Old (50–78) Underweight (n=4) Normal (n=15) Overweight (n=18) Obese (n=11) BMI effect Ageing effect
Age (years) 63.8 (5.7) 63.5 (7.7) 68.2 (4.8) 62.5 (9.0) p=0.183 p=0.001
Height (cm) 159.1 (5.3) 159.4 (5.2) 162.1 (3.8) 162.5 (5.7) p=0.264 p=0.002
Body mass (kg) 48.4 (4.2) 56.6 (4.3) 71.6 (4.5) 90.1 (16.4) p<0.001 p=0.683
BMI (kg/m2) 19.1 (0.8) 22.2 (1.0) 27.3 (1.2) 34.1 (5.7) p<0.001 p=0.625
Body fat (%) 26.5 (2.1) 36.0 (3.6) 42.9 (3.3) 46.1 (5.0) p<0.001 p=0.001
Total body fat (kg) 12.5 (2.0) 19.9 (2.9) 29.8 (3.4) 40.9 (11.3) p<0.001 p=0.376
Total lean mass (kg) 32.8 (2.4) 33.3 (2.4) 37.4 (2.4) 44.7 (6.7) p<0.001 p=0.002
Fat mass leg (kg) 2.8 (0.3) 3.8 (0.7) 5.6 (0.1) 6.5 (2.0) p<0.001 p=0.859
A/G ratio 0.66 (0.09) 0.89 (0.16) 0.97 (0.11) 1.10 (0.08) p<0.001 p=0.062
Data are presented as mean±SD
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Muscle strength
Plantar flexion (PF) and dorsiflexion (DF) MVC torque
was assessed in the dominant limb using an isokinetic
dynamometer (Cybex Norm, Cybex International, New
York, NY, USA). Participants were seated with a hip
angle of 85° and their dominant leg fully extended. The
dominant foot was secured to the footplate of the dyna-
mometer using inextensible straps, ensuring the lateral
malleolus was aligned with the centre of rotation. Par-
ticipants were firmly strapped at the hip, distal thigh and
chest with inextensible straps to minimise movement.
Prior to undertaking any MVCs, the participants com-
pleted a series of warm-up PF and DF contractions.
Participants subsequently performed four isometric
PF (×2) and DF (×2) MVCs with the ankle positioned at
0° (anatomically neutral), with 1–2 min of rest between
efforts. MVCs were repeated if there was >10 % differ-
ence between MVCs to ensure true MVC was obtained.
The highest recorded PF and DF MVCs were used for
subsequent analysis. Surface electromyography (EMG)
of the tibialis anterior (TA) was recorded during all
MVCs to calculate antagonist muscle co-contraction
during PF MVC (see below for details). Verbal encour-
agement and biofeedback were provided during each
effort.
Antagonist muscle co-contraction
EMG (using pre-gelled unipolar Ag-AgCl electrodes
(Medicost, Denmark)) was used to assess muscle co-
contraction of the tibialis anterior during PF MVC. Two
electrodes (skin contact size 30 mm×22 mm) were
placed proximally at one third of the tibialis anterior
muscle length, mid muscle belly, with a 1–2-mm gap
separating each electrode. A reference electrode
(Medicost, Denmark) was placed on the head of the
fibula. Raw EMG was then recorded at 2,000 Hz, with
the band pass filter set at 10–500 Hz and notch at 50 Hz.
Muscle co-contraction (%) was calculated at 0° ankle
angle utilising the raw EMG signal (computed as root
mean square (RMS) 500 ms either side of the instanta-
neous peak torque) of the tibialis anterior during PF
MVC divided by EMG during DF MVC. Co-
contraction torque (Nm) was the product of percent
co-contraction and maximal DF torque.
Hence, net PFMVC torquewas calculated as the sum
of observed maximal PF torque and co-contraction
torque. This method assumes that the DF EMG/torque
relationship is linear (Maganaris et al. 1998).
Muscle activation
PF agonist muscle activation was estimated using the
interpolated twitch technique (Morse et al. 2004;
Pearson and Onambele 2006). Briefly, percutaneous
stimuli (DSV Digitimer Stimulator, Digitimer, Herts.,
UK) were applied to the gastrocnemius using rubber
stimulation pads (50 mm×100 mm; American Imex,
Irvine, CA, USA). The two stimulation pads were
placed transversely distal to the popliteal crease and
myotendinous junction of the soleus. The amplitude of
the stimuli was determined prior to interpolation whilst
the participant was in a relaxed state; administering
twitches starting from 50 mA, with subsequent incre-
ments of 50–100 mA, until no further increase in twitch
torque was elicited. The assessed supramaximal dou-
blets (i.e. the stimulus intensity above which no further
increase in doublet torque was observed with increased
stimulus intensity) were superimposed during a maxi-
mal PF MVC. The calculation used to establish muscle
activation (%) is shown below:
Superimposed doublet torque=resting doublet torqueð Þ  100 ¼ muscle activation %ð Þ
Statistical analyses
Statistical analyses were carried out using SPSS (version
19, SPSS Inc., Chicago, IL, USA). To determine
parametricity, Kolmogorov-Smirnov or Shapiro-Wilk
(normal distribution) and Levene’s tests (homogeneity
of variance) were utilised. If parametric assumptions
were met, a factorial 2×4 ANOVA (age×BMI) was
utilised with post hoc Bonferroni correction for pairwise
comparisons. Where parametric assumptions were
breached, Mann-Whitney U or Kruskal-Wallis H was
utilised. Pearson correlations described the relationships
between PF MVC and leg lean mass, muscle activation,
body mass, fat mass, total lean mass, body fat%, BMI
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and A/G ratio. Additionally, linear and multiple regres-
sions were used to determine the best predictors of PF
MVC. A comparison of the regression coefficients and
slopes was conducted using z transformations and Stu-
dent’s t statistic. Data are reported as mean±SD, and
statistical significance was accepted when p≤0.05.
Study power (β) and effect size (pε2) are also reported.
Results
Body composition
Table 1 displays the descriptive values for age, height,
body mass, BMI, body fat%, total body fat, total lean
mass, leg fat mass and A/G ratio for Y and O females
categorised by BMI. A 2×4 factorial ANOVA of body
fat% revealed a main effect for age (p=0.001; pε2=
0.104; β=0.904) and for BMI (p<0.001; pε2=0.736;
β=1.000) and an age×BMI interaction (p=0.029; pε2=
0.091; β=0.713).
A Mann-Whitney test on leg lean mass revealed a
main effect of age (p<0.001), whilst a Kruskal-Wallis
test revealed between-group differences for leg lean
mass between classifications in Y (p<0.001) and O
(p<0.001). However, Y obese had 28 and 27 % more
leg lean mass than Y underweight (p<0.001) and Y
normal weight (p<0.001) individuals, respectively,
whilst obese O had 26, 27 and 20 % more leg lean mass
than O underweight (p=0.018), O normal weight
(p<0.001) and O overweight (p=0.04), respectively
(Table 4).
There were strong positive correlations (p<0.001)
between leg lean mass and body mass, and lean mass
and body fat, in both Y and O groups (Tables 2 and 3).
Ageing affected neither the degree of association in
these correlations (p>0.05) nor the slope of the regres-
sions (p<0.05, Table 3). In predicting leg lean mass, a
stepwise multiple linear regression was conducted with
variables body fat%, body mass, lean mass, fat mass
and android to gynoid ratio in all individuals. Total
lean mass and body fat% were the only predictors in a
stable model, which, in combination, explained 93 %
of the leg lean mass in both Y and O individuals
(p<0.001; r=0.966).
Muscle strength
A 2×4 factorial ANOVA on PF MVC torque revealed a
main effect for age (p<0.001; pε2=0.327; β=1.000) and
a main effect for BMI (p=0.001; pε2=0.152; β=0.937),
yet there was no significant age×BMI interaction (p=
0.676; pε2=0.016; β=0.151). However, Yobese had 23
and 20 % higher uncorrected PF MVC torque than
underweight (p<0.008) and normal weight (p=0.039)
individuals, whilst O individuals revealed no significant
between-group differences (p>0.05) (Table 4).
PF MVC torque relative to body mass was higher in
Y vs. O (p<0.001; pε2=0.291; β=1.000) and differed
according to BMI (p<0.001; pε2=0.285; β=1.000), but
there was no significant age×BMI interaction (p=
0.410; pε2=0.030; β=0.258). However, Y obese had
43, 35 and 25 % lower PF MVC torque relative to body
mass than Y underweight (p<0.001), Y normal weight
(p<0.001) and Y overweight (p=0.031), respectively,
whilst obese O exhibited 43 % lower uncorrected PF
MVC torque relative to body mass than O underweight
(p=0.032) (Table 4).
The net PFMVC torque revealed a main effect of age
(p<0.001; pε2=0.293; β=1.000) and BMI (p<0.001;
pε2=0.224; β=0.995), but no significant age×BMI in-
teraction (p=0.581; pε2=0.021; β=0.184). However, Y
Table 2 Linear regressions (r2)
between net PF torque, leg lean
mass and agonist muscle activa-
tion against a series of descriptive
variables in young and old un-
trained females
*p<0.05; **p<0.01;
***p<0.001
Young (n=54) Old (n=48)
PF MVC Leg lean
mass
Activation PF MVC Leg lean
mass
Activation
Leg lean mass 0.623*** – 0.179** 0.26*** – NS
Body mass 0.508*** 0.749*** 0.164** 0.204** 0.677*** NS
Fat mass 0.385*** 0.538*** 0.157** 0.135* 0.472*** NS
Lean mass 0.600*** 0.936*** 0.125** 0.242*** 0.904*** NS
Body fat% 0.203** 0.240*** 0.103* NS 0.135* NS
BMI 0.411*** 0.548*** 0.179** 0.157** 0.559*** NS
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obese had 27 and 23% higher corrected PFMVC torque
than Y underweight (p<0.001) and Y normal weight
(p=0.002) individuals, whilst O revealed no significant
between-group differences (p>0.05) (Table 4).
Net PF MVC torque/body mass revealed a main
effect of age (p<0.001; pε2=0.281; β=1.000) and
BMI (p<0.001; pε2=0.280; β=1.000), but no signifi-
cant age×BMI interaction (p=0.821; pε2=0.010; β=
0.107). However, Y obese had 35 and 29 % lower net
PF MVC torque/body mass than Y underweight
(p<0.001) and Y normal weight (p<0.001) individuals,
whilst obese O had 31 % lower net PF MVC torque/
body mass than O normal weight (p=0.016) (Table 4).
There were strong positive correlations (p<0.001)
between net PF MVC torque and body mass, lean mass
and body fat in both Yand O groups (as seen in Table 2).
Ageing affected neither the degree of association in
these correlations (p>0.05) nor the slope of the regres-
sions (p>0.05, Table 3). In predicting net PF MVC, a
stepwise multiple linear regression was conducted with
independent variables being body fat%, bodymass, lean
mass, fat mass and android to gynoid ratio, for the
pooled study population (i.e. all Y and O data). Total
lean mass was the only predictor in the stable model and
explained 51 % of net PF MVC, and body mass nor-
malised torque regardless of age (p<0.001; r=0.710).
Net PF MVC and leg lean mass were correlated in
both the Y (p<0.001; r2=0.623) and O (p<0.001; r2=
0.260) age groups, with similar slopes in the two age
groups (Table 3). Figure 1 displays the percent change
per 10 years (assuming % change is linear) in muscle
loss, PF torque, net PF torque and net PF torque nor-
malised for BM categorised by BMI.
Muscle co-contraction
There was no significant difference in antagonist co-
contraction between BMI groups (p=0.730) (Table 4).
Yet, there was an effect of age, with O exhibiting lower
co-activation than Y (16.1 vs. 13.8 %; p=0.042).
Voluntary muscle activation
Muscle activation did not differ between BMI groups
in either Y (p=0.138) or O (p=0.701) (Table 4). When
Y and O were categorised by body fat% (Fig. 2),
muscle activation was higher in Y low body fat%
(BF%) than Y high BF% (p=0.019) but there was no
difference in O (p=0.458) (Fig. 1). Y also demonstrat-
ed higher muscle activation capacity than O (92 vs.
84.5 %; p=0.001).
Discussion
Our data have provided supportive evidence for our
hypothesis that absolute torque in young obese individ-
uals would be higher compared to that of underweight
and normal weight individuals. However, the old obese
females did not exhibit significantly higher absolute
torque compared to the other three BMI classifications.
Unexpectedly, when torque was normalised to body
mass, the young obese were significantly weaker than
the other three BMI classifications, whereas the old
obese were only weaker than their old underweight
counterparts, thereby suggesting a somewhat protective
impact of obesity for the old, or at least, this suggest that
Table 3 Pearson correlations, z transformation of r and Student’s t statistic between net PF MVC and leg lean mass against a series of
descriptive variables in young and old untrained females
Young Old Correlation coefficient Ageing effect
n r value slope n r value slope z transformation of r Student’s t statistic
PF MVC vs. leg lean mass 54 0.79*** 19.63 48 0.51*** 12.48 1.95 1.90
PF MVC vs. body mass 54 0.71*** 1.26 48 0.45** 0.75 1.70 1.85
PF MVC vs. fat mass 54 0.62*** 1.70 48 0.37* 0.92 1.57 1.70
PF MVC vs. lean mass 54 0.78*** 3.70 48 0.49*** 2.28 1.93 1.94
Leg FFM vs. BM 54 0.87*** 0.06 48 0.83*** 0.06 0.45 0.77
Leg FFM vs. FM 54 0.73*** 0.08 48 0.69*** 0.07 0.35 0.74
Leg FFM vs. lean mass 54 0.97*** 0.19 48 0.95*** 0.18 0.50 0.44
*p<0.05; **p<0.01; ***p<0.001 (If z>1.96, p<0.05; z>2.58, p<0.01) (Student’s t statistic significance if t falls outside ±1.96 p<0.05)
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the effects of ageing and obesity are not necessarily
cumulative where absolute joint torque is concerned.
Another partially supported hypothesis was also the
observation that high adiposity only decreased activa-
tion capacity in the young whereas it had no effect in the
old individuals. The summation of a negative impact of
obesity to ageing in this population was seen in terms of
neuromuscular ageing whereby there were marked dif-
ferences in the slopes of the relationships between adi-
posity, muscle torque and activation capacity. The above
observations culminated in the fact that with torque
normalised for body mass and corrected for activation
and co-activation, the obesity-induced weakness was
true for all pairwise BMI category comparisons in the
young. In the old, however, once torque was normalised
for body mass and corrected for activation and co-
activation, the only significant BMI pairwise difference
was between obese vs. normal weight.
Body composition
The loading effect of chronically high levels of adipos-
ity, body mass and lean mass appears to provide a
stimulus to the antigravity muscles of the lower limb
similar to resistance training of increased muscle mass
(Erskine et al. 2010b) (as shown in Tables 2, 3 and 4).
However, whilst 3 weeks of simulated hypergravity
(Bosco 1985) would cause adaptations at a neurogenic
level, the mean duration of obesity is longitudinal at
13 years (Abdullah et al. 2011), and hence, adaptations
to this condition were not expected to be neural led. At
the muscle level, low-load, high-volume resistance ex-
ercise has been shown to stimulate muscle protein syn-
thesis more than traditional high-load, low-volume re-
sistance exercise (Burd et al. 2010), and our hypothesis
was that obesity would have a similar effect, thus lead-
ing to increased muscle mass and strength over time.
Fig. 1 Relative change (mean %
change per 10 years assuming
percentage change is linear) by
BMI class (a) muscle loss, (b) PF
torque, (c) net PF torque, and (d)
net PF torque normalised for BM
Fig. 2 Impact of ageing on PF
activation capacity in low body
fat (<40 %) and high body fat
(>40 %) individuals. The
threshold set at ≥40 % body fat as
being defined obese is due to
previous work in an adult
population (Rolland et al. 2004).
Data are presented as mean±SD
(*p<0.05; **p<0.01)
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Leg lean mass decreased with age in all BMI classi-
fications, but this age-related decrease was exacerbated
in the overweight and obese individuals who lost 4.5
and 4.3 %, respectively, compared to 2.6 and 3.4 % in
underweight and normal weight individuals every
10 years (data calculated assuming a linear regression,
Fig. 1). This blunted effect of loading in the old partic-
ipants on leg lean mass may possibly be attributed to
lower levels of anabolic circulating hormones such as
insulin-like growth factor-1 (IGF-I) (Galli et al. 2012)
and the increase of catabolic cytokines such as
interleukin-6 (IL-6) and tumour necrosis factor α
(TNF-α) (Visser et al. 2002; Hotamisligil et al. 1995)
seen in older vs. younger individuals.
Muscle strength
Increased adiposity in the young was previously shown
to have a positive effect on the loaded antigravity mus-
cles of the knee extensors in terms of both absolute
MVC isometric torque (Hulens et al. 2001; Maffiuletti
et al. 2007; Abdelmoula et al. 2012) and isokinetic
power (Maffiuletti et al. 2007; Hulens et al. 2002), but
not when torque was normalised to body mass, as obese
individuals were shown to be weaker (Maffiuletti et al.
2007). Our current results in the plantar flexors mirror
these observations.
In the old individuals, there was also a trend of
increasing absolute torque with BMI classification, yet
there were no significant differences in MVC torque
normalised to body mass between BMI classifications
(Table 4), except, where the old obese were significantly
weaker compared to normal weight individuals. This
finding partly supports those of Rolland et al. (2004),
who reported greater absolute knee extensor strength in
the obese. Additionally, the old obese individuals lost
more MVC torque compared to the losses in leg lean
mass (27 vs. 13 %); this is comparable to research by
Delmonico et al. (2009) who attributed losses in strength
to lowering in muscle quality. This may possibly be
attributed to intrinsic changes in muscle properties such
as selected atrophy of type II fibres (Lexell and Taylor
1991) and/or a decrease in muscle fascicle pennation
angle (Morse et al. 2005) normally seen in ageing.
Whilst our old females did not meet the criterion for
sarcopenia (i.e. appendicular skeletal muscle mass÷
height (m2)=mean±SD 9.6±1.5 kg/m2 in this group
vs. ≤5.67 kg/m2 criterion; Newman et al. 2003), they
displayed typical ageing-related characteristics of
significantly lower isometric MVC torque (−25 %,
p<0.001), agonist activation (92.1 vs. 84.5 %, p<0.05)
and leg lean mass (7.03 vs. 5.92 kg, p<0.001). Ageing-
associated α-motor neuron degeneration and denerva-
tion (Brown 1972), higher levels of IL-6 and TNF-α
(Visser et al. 2002) may explain some of these effects.
Assuming the loss of joint torque is linear, PF MVC
torque appeared to be exacerbated in obese individuals
who would lose 9.6 % of maximal torque compared to
5.4, 5.7 and 5.7 % in underweight, normal weight and
overweight individuals every 10 years (data calculated
assuming a linear regression, Fig. 1).
The effect of adiposity per se on muscle strength
suggested a positive association with absolute PF
MVC in both young and old groups (Table 2). Yet, when
factoring total adiposity in a multiple linear regression,
lean muscle mass was the only significant predictor of
PF MVC torque. Since adiposity is not a contractile
tissue, the apparent positive association with muscle
strength can only be due to high adiposity being associ-
ated with greater muscle mass in our population.
Previous research on obesity in ageing and muscle
performance mainly selected the loaded knee extensors
as an indicator of lower limb contractile capacity. The
work presented in this paper is novel in that (a) it utilised
the plantar flexors, a muscle group which has a key
functional relevance to older persons due to its docu-
mented contribution in the maintenance of postural bal-
ance (Onambele et al. 2006a), so much so that approx-
imately 80 % of the variance in postural balance can be
attributed to the functional characteristics of this muscle
group, and (b) obesity also has been documented as
having a detrimental impact on postural balance
(Maffiuletti et al. 2005).
Co-contraction
To our knowledge, this is the first study to describe
antagonist muscle co-contraction in an obese popula-
tion. Our study reports, at face value, a protective effect
of obesity during ageing since old obese individuals had
significantly lower co-contraction than their younger
counterparts (16.1 vs. 13.8 %, p<0.042), thereby poten-
tially contributing to higher agonistic forces and hence
better control of joint motion. This was an unexpected
finding as ageing is associated with increased co-
contraction in the hamstrings (Macaluso et al. 2002)
and the triceps surae (Onambele et al. 2006a). However,
since joint stabilisation through co-contraction is a
AGE (2014) 36:1407–1418 1415
strategy used when muscle weakness is present
(Hortobagyi and DeVita 2000), the old obese are in fact
doubly disadvantaged through being both weaker and
less able to co-contract their antagonist muscles com-
pared to age-matched normal weight counterparts, po-
tentially leading to increased risk of joint pathologies
(Felson 1995).
Voluntary muscle activation
Previous work examining muscle strength differences
between obese and non-obese individuals did not ac-
count for agonist activation and antagonist co-
contraction, thus underestimating the true contractile
torque potential, even when such work normalised
MVC torque to muscle mass (Abdelmoula et al. 2012;
Maffiuletti et al. 2007). Our study demonstrates that
high levels of adiposity, with the threshold set at
≥40 % body fat (Rolland et al. 2009), have a signifi-
cantly negative impact on agonist muscle activation in
Y (88 vs. 94 %) but not O (83 vs. 87 %) individuals.
The Y data supports the Blimkie et al. (1990) study that
reported the agonist activation capacity of obese ado-
lescents aged 15–18 years old to be significantly lower
than that of non-obese counterparts (85 vs. 95 %). It
would therefore appear that unlike simulated
hypergravity which enhances muscle activation
(Bosco et al. 1986), obesity-mediated chronic
overloading has either no (as seen in the O) or a
negative (as seen in the Y) impact on voluntary muscle
activation. This would tend to refute the suggestion by
Bosco et al. (1986) of a neurogenic mechanism for
increased muscle power in the obese. We would argue
therefore that any strengthening effect of obesity would
be through muscular factors such as increased protein
synthesis rate (Burd et al. 2010), which is evidenced
through the phenotypic expression of greater absolute
lean mass in this population.
A limitation of the present study, as with previous
work (Blimkie et al. 1990; Maffiuletti et al. 2007;
Abdelmoula et al. 2012), is the failure to quantify ana-
tomical cross-sectional area and using instead leg lean
mass and estimations of fat-free mass and thigh muscle
mass as an indication of agonist muscle size. Not ac-
counting for muscle fascicle pennation angle (and hence
sarcomeres in parallel) and fascicle length (and hence
sarcomeres in series) limits the ability to explain differ-
ences in force and power. Future work should determine
a more accurate index of muscle size by measuring the
physiological cross-sectional area (muscle volume/
fascicle length) (Fukunaga et al. 1996).
Conclusion
The present study demonstrates that antigravity muscles
adapt to chronically different levels of adiposity in both
young and elderly individuals. Interestingly, the magni-
tude of the effect of obesity in terms of both absolute
MVC joint torque and torque normalised to leg lean
mass appears to be blunted in the older group. Also
notable, the rate of ageing (i.e. the slope of deleterious
changes in neuromuscular properties) in the BMI sub-
categories is most dramatic for the high-adiposity
groups.
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